Epidemiology of Chlamydia trachomatis in the Middle East and north Africa: a systematic review, meta-analysis, and meta-regression

Abstract

Background The epidemiology of Chlamydia trachomatis in the Middle East and north Africa is poorly understood. We aimed to provide a comprehensive epidemiological assessment of C trachomatis infection in the Middle East and north Africa. Methods We did a systematic review of C trachomatis infection as well as a meta-analysis and meta-regression of C trachomatis prevalence. We searched PubMed and Embase, as well as regional and national databases up to March 13, 2019, using broad search terms with no language or year restrictions. Any document or report including biological measures for C trachomatis prevalence or incidence was eligible for inclusion. We extracted all measures of current (genital or rectal), recent, and ever infection with C trachomatis. We estimated pooled average prevalence in different populations using random-effects meta-analysis. Factors associated with prevalence and sources of betweenstudy heterogeneity were determined using meta-regression. Findings We identified a total of 1531 citations, of which 255 reports contributed to 552 C trachomatis prevalence measures from 20 countries. No incidence measures were identified. Pooled prevalence of current genital infection was 3•0% (95% CI 2•3-3•8) in general populations, 2•8% (1•0-5•2) in intermediate-risk populations, 13•2% (7•2-20•7) in female sex workers, 11•3% (9•0-13•7) in infertility clinic attendees, 12•4% (7•9-17•7) in women with miscarriage, 12•4% (9•4-15•7) in symptomatic women, and 17•4% (12•5-22•8) in symptomatic men. Pooled prevalence of current rectal infection was 7•7% (4•2-12•0) in men who have sex with men. Substantial between-study heterogeneity was found. Multivariable meta-regression explained 29•0% of variation. Population type was most strongly associated with prevalence. Additional associations were found with assay type, sample size, country, and sex, but not with sampling methodology or response rate (about 90% of studies used convenience sampling and >75% had unclear response rate). There was no evidence for temporal variation in prevalence between 1982 and 2018. Interpretation C trachomatis prevalence in the Middle East and north Africa is similar to other regions, but higher than expected given its sexually conservative norms. High prevalence in infertility clinic attendees and in women with miscarriage suggests a potential role for C trachomatis in poor reproductive health outcomes in this region.

The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa

“…Notably, no small‐study effect, i.e. studies with smaller sample size yielding different antibody prevalence, was found. Similarly, the sampling method had no effect on observed antibody prevalence.…”

Sexually Transmitted Infections: Risk-Factors among Married Female Patients’ in Assiut, Egypt

“…We showed CT infection was 5.0%. In Egypt, CT prevalence was 1.3%-52.0% among different categories of patients 37 . Our figure is parallel to El-Kettani et al 35 (3.8%) and Mosbah &Nabiel 38 (4.4%) figures', higher than El-Moselhy et al 27 (3.0%) and lower than Javanmard et al 39 (11.4%).…”

Hepatitis C Virus Infection in Populations With Liver‐Related Diseases in the Middle East and North Africa

“…Univariable and multivariable random‐effects meta‐regressions were performed based on established methodology to assess predictors of HCV prevalence in populations with LRDs, trend in prevalence over time, and sources of between‐study heterogeneity. A priori relevant independent variables included type of population with LRDs, country, sample size (<100 or ≥10 to investigate a small‐study effect), year of data collection, and year of publication. The country variable included Egypt, Pakistan, and other MENA countries.…”